Logo image of SNES

SENESTECH INC (SNES) Stock Fundamental Analysis

NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock - Currency: USD

4.67  -0.16 (-3.31%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SNES. SNES was compared to 193 industry peers in the Pharmaceuticals industry. SNES may be in some trouble as it scores bad on both profitability and health. SNES is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SNES had negative earnings in the past year.
In the past year SNES has reported a negative cash flow from operations.
In the past 5 years SNES always reported negative net income.
SNES had a negative operating cash flow in each of the past 5 years.
SNES Yearly Net Income VS EBIT VS OCF VS FCFSNES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

SNES has a worse Return On Assets (-165.84%) than 88.08% of its industry peers.
The Return On Equity of SNES (-208.30%) is worse than 69.95% of its industry peers.
Industry RankSector Rank
ROA -165.84%
ROE -208.3%
ROIC N/A
ROA(3y)-145.75%
ROA(5y)-129.64%
ROE(3y)-183.78%
ROE(5y)-169.89%
ROIC(3y)N/A
ROIC(5y)N/A
SNES Yearly ROA, ROE, ROICSNES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

The Gross Margin of SNES (61.34%) is better than 70.47% of its industry peers.
In the last couple of years the Gross Margin of SNES has grown nicely.
SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
SNES Yearly Profit, Operating, Gross MarginsSNES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
SNES has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SNES has been increased compared to 5 years ago.
SNES has a worse debt/assets ratio than last year.
SNES Yearly Shares OutstandingSNES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SNES Yearly Total Debt VS Total AssetsSNES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -50.16, we must say that SNES is in the distress zone and has some risk of bankruptcy.
SNES has a worse Altman-Z score (-50.16) than 92.75% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that SNES is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.07, SNES perfoms like the industry average, outperforming 51.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -50.16
ROIC/WACCN/A
WACC9.98%
SNES Yearly LT Debt VS Equity VS FCFSNES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 5.85 indicates that SNES has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.85, SNES is doing good in the industry, outperforming 75.65% of the companies in the same industry.
A Quick Ratio of 4.46 indicates that SNES has no problem at all paying its short term obligations.
The Quick ratio of SNES (4.46) is better than 66.32% of its industry peers.
Industry RankSector Rank
Current Ratio 5.85
Quick Ratio 4.46
SNES Yearly Current Assets VS Current LiabilitesSNES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.76% over the past year.
Looking at the last year, SNES shows a very strong growth in Revenue. The Revenue has grown by 39.64%.
Measured over the past years, SNES shows a very strong growth in Revenue. The Revenue has been growing by 67.70% on average per year.
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.25%
Revenue 1Y (TTM)39.64%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%16.87%

3.2 Future

The Earnings Per Share is expected to grow by 14.28% on average over the next years. This is quite good.
Based on estimates for the next years, SNES will show a very strong growth in Revenue. The Revenue will grow by 76.45% on average per year.
EPS Next Y36.16%
EPS Next 2Y18.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year103.47%
Revenue Next 2Y91.38%
Revenue Next 3Y76.45%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SNES Yearly Revenue VS EstimatesSNES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
SNES Yearly EPS VS EstimatesSNES Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10K -20K -30K -40K -50K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SNES reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SNES is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNES Price Earnings VS Forward Price EarningsSNES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNES Per share dataSNES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

SNES's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.6%
EPS Next 3Y14.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNES!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENESTECH INC

NASDAQ:SNES (7/17/2025, 5:01:05 PM)

4.67

-0.16 (-3.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-06 2025-08-06
Inst Owners0.98%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change0%
Market Cap8.45M
Analysts82.86
Price Target10.2 (118.42%)
Short Float %45.22%
Short Ratio5.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.39
P/FCF N/A
P/OCF N/A
P/B 2.91
P/tB 2.91
EV/EBITDA N/A
EPS(TTM)-9.97
EYN/A
EPS(NY)-5.92
Fwd EYN/A
FCF(TTM)-3.25
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS1.06
BVpS1.6
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -165.84%
ROE -208.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.34%
FCFM N/A
ROA(3y)-145.75%
ROA(5y)-129.64%
ROE(3y)-183.78%
ROE(5y)-169.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 75%
Cap/Sales 6.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.85
Quick Ratio 4.46
Altman-Z -50.16
F-Score3
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)83.86%
Cap/Depr(5y)64.57%
Cap/Sales(3y)11.18%
Cap/Sales(5y)18.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.25%
EPS Next Y36.16%
EPS Next 2Y18.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)39.64%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%16.87%
Revenue Next Year103.47%
Revenue Next 2Y91.38%
Revenue Next 3Y76.45%
Revenue Next 5YN/A
EBIT growth 1Y19.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.9%
EBIT Next 3Y19.27%
EBIT Next 5YN/A
FCF growth 1Y32.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.79%
OCF growth 3YN/A
OCF growth 5YN/A